Ipilimumab/nivolumabLack of efficacy and autoimmune colitis: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2035卷 / 1期

关键词：

D O I：

10.1007/s40278-024-71002-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：252 / 252

相关论文

共 50 条

[41] PembrolizumabInterstitial pneumonia and autoimmune colitis: 2 case reports
Reactions Weekly, 2020, 1799 (1) : 306 - 306
[42] IpilimumabOcular myositis and autoimmune colitis: 2 case reports
Reactions Weekly, 2017, 1676 (1) : 174 - 174
[43] Atezolizumab/durvalumab/nivolumabLack of efficacy and pneumonitis: 4 case reports
Reactions Weekly, 2020, 1822 (1) : 58 - 58
[44] A Case of Perforating Ipilimumab-Induced Autoimmune Colitis
Sprung, Brandon
Sathyamurthy, Anjana
Lewis, Jennifer
Cellini, Christina
DeCross, Arthur
Kaul, Vivek
Kothari, Shivangi
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S409 - S409
[45] Ipilimumab/nivolumab/prednisoloneHepatitis and lack of efficacy: 2 case reports
Reactions Weekly, 2021, 1865 (1) : 246 - 246
[46] Ipilimumab/nivolumab/immunosuppressantsHepatitis and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1926 (1) : 281 - 281
[47] Ipilimumab/nivolumabPoor tolerance and lack of efficacy: 2 case reports
Reactions Weekly, 2024, 2032 (1) : 224 - 224
[48] Ipilimumab/pembrolizumabSevere polyarthritis and colitis: 3 case reports
Reactions Weekly, 2018, 1683 (1) : 391 - 391
[49] Atezolizumab/ipilimumab/nivolumabLymphocytic colitis : 3 case reports
Reactions Weekly, 2018, 1700 (1) : 47 - 47
[50] Ipilimumab/nivolumabRash, colitis and hepatitis: 6 case reports
Reactions Weekly, 2017, 1657 (1) : 250 - 250

← 1 2 3 4 5 →